BindingDB logo
myBDB logout

BDBM50301253 4-guanidino-N-(4-(2-(2-hydroxy-2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)-2-methylpropyl)phenyl)butanamide::CHEMBL577917

SMILES: [#6]C([#6])([#6]-c1ccc(-[#7]-[#6](=O)-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])cc1)[#7]-[#6]-[#6](-[#8])-c1ccc(-[#8])c2-[#7]-[#6](=O)-[#6]-[#8]-c12

InChI Key: InChIKey=KRTHJCYGNSJFOY-UHFFFAOYSA-N

Data: 2 EC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50301253   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Beta-1 adrenergic receptor


(Homo sapiens (Human))
BDBM50301253
PNG
(4-guanidino-N-(4-(2-(2-hydroxy-2-(5-hydroxy-3-oxo-...)
Show SMILES [#6]C([#6])([#6]-c1ccc(-[#7]-[#6](=O)-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])cc1)[#7]-[#6]-[#6](-[#8])-c1ccc(-[#8])c2-[#7]-[#6](=O)-[#6]-[#8]-c12
Show InChI InChI=1S/C25H34N6O5/c1-25(2,12-15-5-7-16(8-6-15)30-20(34)4-3-11-28-24(26)27)29-13-19(33)17-9-10-18(32)22-23(17)36-14-21(35)31-22/h5-10,19,29,32-33H,3-4,11-14H2,1-2H3,(H,30,34)(H,31,35)(H4,26,27,28)
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1.80n/an/an/an/a



Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL


Assay Description
Agonist activity at human beta-1 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level


Bioorg Med Chem Lett 19: 5237-40 (2009)


Article DOI: 10.1016/j.bmcl.2009.06.104
BindingDB Entry DOI: 10.7270/Q2PN95Q8
More data for this
Ligand-Target Pair
Beta-2 adrenergic receptor


(Homo sapiens (Human))
BDBM50301253
PNG
(4-guanidino-N-(4-(2-(2-hydroxy-2-(5-hydroxy-3-oxo-...)
Show SMILES [#6]C([#6])([#6]-c1ccc(-[#7]-[#6](=O)-[#6]-[#6]-[#6]\[#7]=[#6](\[#7])-[#7])cc1)[#7]-[#6]-[#6](-[#8])-c1ccc(-[#8])c2-[#7]-[#6](=O)-[#6]-[#8]-c12
Show InChI InChI=1S/C25H34N6O5/c1-25(2,12-15-5-7-16(8-6-15)30-20(34)4-3-11-28-24(26)27)29-13-19(33)17-9-10-18(32)22-23(17)36-14-21(35)31-22/h5-10,19,29,32-33H,3-4,11-14H2,1-2H3,(H,30,34)(H,31,35)(H4,26,27,28)
PDB
MMDB

Reactome pathway
KEGG

UniProtKB/SwissProt
UniProtKB/TrEMBL

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/an/an/a 1n/an/an/an/a



Boehringer Ingelheim Pharma GmbH& Co. KG

Curated by ChEMBL


Assay Description
Agonist activity at human beta2 adrenoceptor expressed in CHOK1 cell assessed as increase of intracellular cAMP level


Bioorg Med Chem Lett 19: 5237-40 (2009)


Article DOI: 10.1016/j.bmcl.2009.06.104
BindingDB Entry DOI: 10.7270/Q2PN95Q8
More data for this
Ligand-Target Pair